Newsroom
Sorted by: Latest
-
BNY Mellon Emerging Markets Equity ETF Announces Change in Frequency of Dividend Distributions
NEW YORK--(BUSINESS WIRE)--BNY Mellon ETF Investment Adviser, LLC announced today that the Board of Trustees of BNY Mellon ETF Trust has approved a change in the frequency of income dividend distributions by BNY Mellon Emerging Markets Equity ETF (NYSE Arca: BKEM) from quarterly to semi-annually. Income dividend distributions, if any, for the fund will generally be distributed to shareholders semi-annually, but may vary significantly from period to period. Net capital gains for the fund will co...
-
Samenvatting: Clinilabs vestigt haar EU-hoofdzetel in Basel en versterkt haar Europese klinische activiteiten onder een nieuw regionaal bestuur
NEW YORK & BASEL, Zwitserland--(BUSINESS WIRE)--Clinilabs, een vooraanstaande gespecialiseerde CRO (contract research organization) die zich richt op de ontwikkeling van geneesmiddelen en apparatuur voor het centrale zenuwstelsel (CNS), kondigde vandaag de uitbreiding aan van haar Europese activiteiten, inclusief de vestiging van haar hoofdzetel voor de Europese Unie in de Switzerland Innovation Park Basel Area, en de benoeming van Dr. Anne-Marie Nagy tot executive vicevoorzitter en hoofd van C...
-
Fifth Third Bancorp to Participate in the RBC Capital Markets Financial Institutions Conference
CINCINNATI--(BUSINESS WIRE)--Fifth Third Bancorp (Nasdaq: FITB) will participate in the 2026 RBC Capital Markets Financial Institutions Conference on March 11, 2026, at approximately 11:20 AM ET. Bryan Preston, executive vice president and chief financial officer, and Kevin Khanna, executive vice president and head of commercial bank, will represent the Company. Audio webcast and any presentation slides may be viewed live and for approximately 14 days after the conference through the Investor R...
-
Resumen: Clinilabs radica su sede central en la UE en Basilea y consolida sus operaciones clínicas europeas con un nuevo liderazgo regional
NUEVA YORK Y BASILEA, Suiza--(BUSINESS WIRE)--Clinilabs, especialista líder en investigación por contrato (CRO) centrada en el desarrollo de fármacos y dispositivos para el sistema nervioso central (SNC), ha anunciado hoy la ampliación de sus operaciones en Europa, en particular, al establecer su sede en la Unión Europea en el parque industrial Switzerland Innovation Park Basel Area y el nombramiento de la Dra. Anne-Marie Nagy como vicepresidente ejecutiva y directora de Clinilabs Europe. Switz...
-
Andersen Consulting renforce ses capacités grâce à Assure Consulting
SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting consolide sa plateforme avec l'arrivée d'Assure Consulting, une société allemande de conseil spécialisée dans la gestion de projets et de portefeuilles de projets. Le cabinet Assure Consulting, créé en 2003, aide les entreprises à réussir leurs projets et transformations complexes. Il accompagne ses clients dans la création et l'exploitation de bureaux de gestion de projets (PMO - Projet Management Offices), dans la consolidation de la gouvern...
-
Record Results Headlined by a Fourth Quarter 62% increase in Earnings Per Share for Exchange Income Corporation Driven by Strong Foundations and Accelerating Growth
WINNIPEG, Manitoba--(BUSINESS WIRE)--Record Results Headlined by a Fourth Quarter 62% increase in Earnings per Share for EIC driven by Strong Foundations and Accelerating Growth...
-
MGE Energy Reports Fourth-Quarter and Full-Year 2025 Earnings
MADISON, Wis.--(BUSINESS WIRE)--MGE Energy Reports Fourth-Quarter and Full-Year 2025 Earnings...
-
Dream Impact Trust Provides Update on Quayside Development
TORONTO--(BUSINESS WIRE)--DREAM IMPACT TRUST (TSX: MPCT.UN) ("Dream Impact", "we", "our" or "Trust") today provides an investment update on the Quayside project. “We are pleased to announce the completion of the Quayside partnership reorganization, which is a significant accomplishment at one of our milestone projects,” said Michael Cooper, Portfolio Manager. “Collectively, the Trust and Dream Impact Fund now own 100% of the phase 1 multi-family portfolio on a 25%/75% basis. Upon completion, Ph...
-
AlgoSec Achieves Protected Level under the Australian Government’s Infosec Registered Assessors Programme (IRAP) Framework
RIDGEFIELD PARK, N.J.--(BUSINESS WIRE)--AlgoSec's SaaS platform has been assessed and certified to the Protected level under the Infosec Registered Assessors Programme (IRAP) framework....
-
3ME Technology and South 8 Technologies Sign Letter of Intent to Advance Extreme Cold‑Weather Battery Solutions for Defense
SAN DIEGO--(BUSINESS WIRE)--South 8 Technologies, a San Diego-based innovator redefining lithium-ion battery performance with its patented LiGas® cell technology, has signed a Letter of Intent (LOI) with 3ME Technology, an Australian‑owned specialist in ultra‑safe lithium‑ion battery systems for defense, mining and maritime operations, to collaborate on the development of next‑generation lithium‑ion battery solutions designed for extreme cold‑weather and Arctic defense operations. The LOI estab...